An open randomized comparative study to evaluate effectiveness and tolerability of blood schizonticide treatments with Eurartesim® versus chloroquin for uncomplicated malaria due to monoinfection of Plasmodium vivax

Objectives

*Original title in Portuguese: Um estudo aberto randomizado comparativo para avaliar eficácia e tolerabilidade de tratamentos esquizonticidas sanguíneos com Eurartesim® versus cloroquina para malária não complicada por monoinfecção de Plasmodium vivax

This study aims to demonstrate the superiority of the parasitological response on day 42 of Dihydroartemisinin plus Piperaquine (DHAPQP) – Eurartesim® versus Chloroquine and to evaluate the proportion of failure until day 180, considering different days of introduction of Primaquine at a dose of 0.50 mg on a kg/day basis, for 14 days.